Statistics

Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database88

Select a period of time:

Number of views in the range

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database25

Views

Views
November 20251
December 20252
January 202612
February 20260
March 20265
April 20260
May 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Finland6
United Kingdom2
Argentina1
Colombia1
Ethiopia1
Mexico1
Tunisia1
 

Top cities views

Views
Helsinki5
Los Angeles3
Council Bluffs2
Addis Ababa1
Celaya1
Fair Oaks1
Kansas City1
Mar del Plata1
Montería1
Oceana1